Pupm&Dump trading strategy idea.
$SYBX is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $4,16;
stop-loss — $4,58;
take-profit — $3,32/MOC
Do not view this idea as a recommendation for trading or investing. It is...
BREAKOUT STOCK ALERT UPDATE
$SYBX - Synlogic, Inc. - Common Stock
Initial Alert Price: $2.50
Price High: $3.97
% Gains/Losses: 58.8%
(58.68% More Than Expected)
Stop Loss Limit: $3.77
SYBX EMA Crossover going green for the first time since $4.00 High on Nov. 25th after the U.S. government has agreed to loan Synlogic partner Ginko Bioworks $1.1 billion for...
BREAKOUT STOCK ALERT
$SYBX - Synlogic, Inc. - Common Stock
Initial Price: $2.50
Potential Price: $2.80
Potential Gains: 12%
Stop Loss Limit: $2.38
SYBX EMA Crossover going green for the first time since $4.00 High on Nov. 25th after the U.S. government has agreed to loan Synlogic partner Ginko Bioworks $1.1 billion for COVID-19 testing and the production of raw...
Contextual immersion trading strategy idea.
Synlogic is a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States.
The demand for shares of the company looks higher than the supply.
These and other conditions can cause a rise in...
Synlogic, Inc. engages in the discovery and development of Synthetic Biotic medicines. It focuses in Phenylketonuria, Enteric Hyperoxaluria, Immuno Oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.
NASDAQ
